China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Holders of 5% or more of SXTC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of China SXT Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Foong Soon Hong,randy | 13G | 9.12%10.6M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
| Tan Soo Seng | 13G | 8.95%10.4M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
| Tan Cheng Guan | 13G | 8.79%10.2M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
| Ching Choon Hwa | 13G | 8.45%9.80M shares | New | Aug 7, 20251 filing | Aug 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
7 Schedule 13D and 13G filings on China SXT Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 20258:49 AM ET | Ching Choon Hwa | 13G | 8.45%9.80M shares | New | Jul 29, 2025 | SEC |
| Aug 7, 20258:44 AM ET | Tan Soo Seng | 13G | 8.95%10.4M shares | New | Jul 29, 2025 | SEC |
| Aug 7, 20258:38 AM ET | Tan Cheng Guan | 13G | 8.79%10.2M shares | New | Jul 29, 2025 | SEC |
| Aug 7, 20258:31 AM ET | Foong Soon Hong,randy | 13G | 9.12%10.6M shares | New | Jul 29, 2025 | SEC |
| Jan 21, 20251:01 PM ET | Streeterville Capital LLCand 2 others | 13G/A | 0.00%0 shares | –Below 5% | Jan 17, 2025 | SEC |
| Feb 16, 2021 | Ayrton Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Hudson Bay Capital Management LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell China SXT Pharmaceuticals, Inc. shares.
No Form 144 notices for China SXT Pharmaceuticals, Inc. are on file.